Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Genor Biopharma Co., Ltd.)"
Count: 18
Selected: 0
NCT IDTitle
NCT04923048A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.
NCT04905667Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®
NCT04179513A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients
NCT04178850Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection
NCT04178070Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects
NCT04178057Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
NCT04178044Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection
NCT04175171Clinical Trial of Comparative Study of GB221 Pharmacokinetics
NCT04175158Clinical Trial in Chinese Healthy Volunteers of GB222
NCT04170595Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection
NCT04164615Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection
NCT03977090Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer
NCT03976856Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib
NCT03808857A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive
NCT03639181Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226)
NCT03623581Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)
NCT03502629Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)
NCT03374007Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma